Storia in 19 fonti

Doctors explain how Moderna's melanoma mRNA vaccine could fight deadliest form of skin cancer

CBS News medical correspondent Dr. Céline Gounder, who has had melanoma herself, said Moderna's experimental trial is "a big win for mRNA vaccines against cancer."

Raccontata da

fortune.com+7 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

cbsnews.comStai leggendo7 h fa

Doctors explain how Moderna's melanoma mRNA vaccine could fight deadliest form of skin cancer

CBS News medical correspondent Dr. Céline Gounder, who has had melanoma herself, said Moderna's experimental trial is "a big win for mRNA vaccines against cancer."

originale

Timeline cronologica

mercoledì 19 agosto 2026·en.mercopress.com
A personalized mRNA therapy passes a phase 3 melanoma trial for the first time
Pharmaceutical companies Merck, known as MSD outside the United States and Canada, and Moderna announced on Wednesday that their individualized neoantigen therapy, intismeran…
mercoledì 19 agosto 2026·biopharmadive.com
Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma
At an interim data check, investigators of a key trial found the individualized mRNA treatment kept disease from returning and stopped its spread, sparking a surge in Moderna…

Doctors explain how Moderna's melanoma mRNA vaccine could fight deadliest form of skin cancer

Confronto fonti

Doctors explain how Moderna's melanoma mRNA vaccine could fight deadliest form of skin cancer

Timeline cronologica

A personalized mRNA therapy passes a phase 3 melanoma trial for the first time

Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma

Merck, Moderna say melanoma vaccine meets goals in large trial | CBC News

‘Landmark’: New mRNA vaccine could prevent skin cancer from returning, companies say

Skin cancer breakthrough delivers second act for Moderna's mRNA vaccines | The National

Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma

New Melanoma Vaccine Shows Promise In Fighting Cancer, Preventing Recurrence

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

Merck, Moderna say melanoma vaccine meets goals in large trial | CBC News

Anuncian resultados positivos de una vacuna contra el cáncer de piel

'Landmark moment' as vaccine stops cancer returning in striking trial

‘First time’: Drug giants’ cancer breakthrough

Melanoma, nuove speranze da vaccino sperimentale di Moderna e Merck: "Risultati promettenti" - Il Quotidiano del Sud

Krebstherapie: Moderna meldet positive Ergebnisse in Studie zu Hautkrebs-Impfstoff

¿Cómo es la vacuna contra el cáncer de piel de Moderna y por qué ha sacudido los mercados?

Moderna annuncia risultati sul vaccino mRna contro il melanoma, superato test di fase 3 su cancro della pelle

Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks…

Nova vacina de mRNA pode impedir o retorno do câncer de pele

For Moderna, cancer vaccine results ease investor skepticism on its future as stock soars

Moderna and Merck shares soar on mRNA cancer vaccine

New Cancer Treatment Hope After mRNA Vaccine Success

Moderna y Merck anuncian el éxito de su vacuna contra el melanoma tras un ensayo con resultados prometedores

Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread

‘Landmark’: New mRNA vaccine could prevent skin cancer from returning, companies say

Vacuna contra el melanoma: cómo funciona la tecnología de ARN mensajero que genera expectativas